These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21931769)

  • 1. Suppression of breast tumor growth and metastasis by an engineered transcription factor.
    Beltran AS; Russo A; Lara H; Fan C; Lizardi PM; Blancafort P
    PLoS One; 2011; 6(9):e24595. PubMed ID: 21931769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors.
    Beltran A; Parikh S; Liu Y; Cuevas BD; Johnson GL; Futscher BW; Blancafort P
    Oncogene; 2007 Apr; 26(19):2791-8. PubMed ID: 17057734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs).
    Beltran AS; Blancafort P
    Epigenetics; 2011 Feb; 6(2):224-35. PubMed ID: 20948306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor.
    Beltran AS; Sun X; Lizardi PM; Blancafort P
    Mol Cancer Ther; 2008 May; 7(5):1080-90. PubMed ID: 18483297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors.
    Lara H; Wang Y; Beltran AS; Juárez-Moreno K; Yuan X; Kato S; Leisewitz AV; Cuello Fredes M; Licea AF; Connolly DC; Huang L; Blancafort P
    J Biol Chem; 2012 Aug; 287(35):29873-86. PubMed ID: 22782891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
    Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
    Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
    Piperigkou Z; Franchi M; Götte M; Karamanos NK
    Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.
    Zhu S; Wu H; Wu F; Nie D; Sheng S; Mo YY
    Cell Res; 2008 Mar; 18(3):350-9. PubMed ID: 18270520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
    Liu Z; Shi HY; Nawaz Z; Zhang M
    Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.
    Villares GJ; Zigler M; Dobroff AS; Wang H; Song R; Melnikova VO; Huang L; Braeuer RR; Bar-Eli M
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):626-31. PubMed ID: 21187389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells.
    Amir S; Margaryan NV; Odero-Marah V; Khalkhali-Ellis Z; Hendrix MJ
    Cancer Biol Ther; 2005 Apr; 4(4):400-6. PubMed ID: 15846059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytoplasmic localization of maspin in promoting cell invasion in breast cancer with aggressive phenotype.
    Sakabe T; Wakahara M; Shiota G; Umekita Y
    Sci Rep; 2021 May; 11(1):11321. PubMed ID: 34059749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Snail transcription factor negatively regulates maspin tumor suppressor in human prostate cancer cells.
    Neal CL; Henderson V; Smith BN; McKeithen D; Graham T; Vo BT; Odero-Marah VA
    BMC Cancer; 2012 Aug; 12():336. PubMed ID: 22857708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer.
    Augoff K; McCue B; Plow EF; Sossey-Alaoui K
    Mol Cancer; 2012 Jan; 11():5. PubMed ID: 22289355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors.
    Maekawa T; Sano Y; Shinagawa T; Rahman Z; Sakuma T; Nomura S; Licht JD; Ishii S
    Oncogene; 2008 Feb; 27(8):1045-54. PubMed ID: 17700520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
    Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
    Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and regulation of tumor suppressor gene maspin in breast cancer.
    Maass N; Nagasaki K; Ziebart M; Mundhenke C; Jonat W
    Clin Breast Cancer; 2002 Oct; 3(4):281-7. PubMed ID: 12425757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling human breast cancer metastasis in mice: maspin as a paradigm.
    Shi HY; Zhang W; Liang R; Kittrell F; Templeton NS; Medina D; Zhang M
    Histol Histopathol; 2003 Jan; 18(1):201-6. PubMed ID: 12507299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear location of tumor suppressor protein maspin inhibits proliferation of breast cancer cells without affecting proliferation of normal epithelial cells.
    Machowska M; Wachowicz K; Sopel M; Rzepecki R
    BMC Cancer; 2014 Feb; 14():142. PubMed ID: 24581141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple functions of maspin in tumor progression and mouse development.
    Zhang M
    Front Biosci; 2004 Sep; 9():2218-26. PubMed ID: 15353283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.